Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A Single-Center Experience and Literature Review of Management Strategies for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Patients.
Majeed A, Larriva MM, Iftikhar A, Mushtaq A, Campbell P, Nadeem Malik M, Rafae A, Zar MA, Kamal A, Lakhani M, Khalid NR, Zangeneh TT, Anwer F. Majeed A, et al. Among authors: zar ma. Infect Dis Clin Pract (Baltim Md). 2020 Jan;28(1):10-15. doi: 10.1097/ipc.0000000000000798. Infect Dis Clin Pract (Baltim Md). 2020. PMID: 33424210 Free PMC article.
Evidence-based supportive care in multiple myeloma.
Qureshi A, Tariq MJ, Shah Z, Abu Zar M, Aslam S, Rafae A, Shafqat M, Malik MN, Faisal MS, Anwer F. Qureshi A, et al. Among authors: abu zar m. J Community Hosp Intern Med Perspect. 2020 Aug 2;10(4):313-317. doi: 10.1080/20009666.2020.1771124. J Community Hosp Intern Med Perspect. 2020. PMID: 32850087 Free PMC article. Review.
Treatment of relapsed multiple myeloma: Evidence-based recommendations.
Durer C, Durer S, Lee S, Chakraborty R, Malik MN, Rafae A, Zar MA, Kamal A, Rosko N, Samaras C, Valent J, Chaulagain C, Anwer F. Durer C, et al. Among authors: zar ma. Blood Rev. 2020 Jan;39:100616. doi: 10.1016/j.blre.2019.100616. Epub 2019 Aug 31. Blood Rev. 2020. PMID: 31500848 Review.
Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials.
Mushtaq A, Iftikhar A, Hassan H, Lakhani M, Sagar F, Kamal A, Zahid U, Ali Z, Razzaq F, Zar MA, Hassan SF, Safdar A, Raychaudhuri S, Anwer F. Mushtaq A, et al. Among authors: zar ma. Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):447-461. doi: 10.1016/j.clml.2019.04.003. Epub 2019 Apr 6. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31060991
Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma.
Anwer F, Gee KM, Iftikhar A, Baig M, Russ AD, Saeed S, Zar MA, Razzaq F, Carew J, Nawrocki S, Al-Kateb H, Cavalcante Parr NN, McBride A, Valent J, Samaras C. Anwer F, et al. Among authors: zar ma. Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):397-405. doi: 10.1016/j.clml.2019.03.017. Epub 2019 Mar 25. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31036508 Free PMC article. Review.
79 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page